Key Elements of the Plan

The plan includes appropriate therapeutic area information and summarizes completed and planned preclinical, clinical and drug manufacturing/QA activities. It includes sufficient detail to facilitate project management to the next major milestone. Information on market size and competitive landscape is also included along with financial plans and budget to support valuation modeling which is useful for both investors and potential licensees.